Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 24 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

14 of 21 completed trials have results

Key Signals

1 recruiting14 with results

Enrollment Performance

Analytics

Phase 1
22(91.7%)
N/A
1(4.2%)
Phase 2
1(4.2%)
24Total
Phase 1(22)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07176208Phase 1Recruiting

Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults

Role: collaborator

NCT06192589Phase 1Completed

Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions

Role: collaborator

NCT05470465Phase 1Completed

Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation

Role: collaborator

NCT04815993Phase 1Completed

Pharmacokinetics, Safety, and Tolerability of SYN-020

Role: collaborator

NCT05168501Not ApplicableCompleted

Assessing Variability of the Ventilatory Response to Duffin's Rebreathing Procedure

Role: collaborator

NCT04310579Phase 1Completed

Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation

Role: collaborator

NCT04183192Phase 1Completed

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists

Role: collaborator

NCT04189484Phase 1Completed

Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors

Role: collaborator

NCT04183491Phase 1Completed

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products

Role: collaborator

NCT04764630Phase 1Completed

Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone

Role: collaborator

NCT04505397Phase 1Completed

Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects

Role: collaborator

NCT05716854Phase 1Completed

Electrophysiological Effects of Potential QT Prolonging Drugs

Role: collaborator

NCT03529487Phase 1Unknown

Intra-anal Oxymetazoline in Healthy Adult Volunteers

Role: collaborator

NCT05045833Phase 1Completed

Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020

Role: collaborator

NCT04397445Phase 1Completed

Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration

Role: collaborator

NCT04355286Phase 1Completed

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

Role: collaborator

NCT03582215Phase 1Completed

Assessment of the Human Systemic Absorption of Sunscreen Ingredients

Role: collaborator

NCT03070470Phase 1Completed

CiPA Phase 1 ECG Biomarker Validation Study

Role: collaborator

NCT03171415Phase 2Completed

Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers

Role: collaborator

NCT02581072Phase 1Completed

A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204

Role: collaborator